The global sterilization monitoring technologies market is valued at $638.8M in 2023 and is projected to reach $1.1B by 2033, growing at a 6.5% CAGR, according to Fact.MR.
Sterilization technologies eliminate organisms like bacteria, pathogens, and fungi. Monitoring technologies are widely used in hospitals, pharma, biotech, and research institutes, with biological, chemical, and mechanical methods.
Download a Free Sample Copy of this Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=8391
Market growth is driven by rising hospital-acquired infections and increased surgical procedures. North America leads the market, with Europe expected to grow rapidly due to pharma and biotech expansion.
Key Takeaways:
- Market to grow at 6.5% CAGR (2023–2033).
- Germany’s market to grow at 5% CAGR; China at 6%.
- Biological monitoring technologies to rise at 7% CAGR.
Segmentation:
- Technology: Biological, Chemical, Mechanical
- Product: Biological & Chemical Indicators
- Method: Steam, Ethylene Oxide, Hydrogen Peroxide, Formaldehyde
- Process: Pack, Load, Equipment, Exposure Monitoring
- End Users: Hospitals, Pharma, Biotech, Research
Competitive Landscape:
- Sterigenics upgraded its E-beam facility (May 2022).
- 3M launched the Attest Mini Auto-reader 490M (July 2020).
- STEMart introduced microbial testing (June 2022).
Leading companies include 3M, Cardinal Health, Getinge AB, and Steris PLC.
Comments
0 comment